These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2596856)

  • 1. [Treatment of acute leukemia with "MB-triple V" therapy--a comparative study of "MB-triple V" therapy and B-triple V therapy].
    Yamane T; Inoue T; Furukawa Y; Sasaki A; Kishida T; Park K; Im T; Tatsumi N
    Gan To Kagaku Ryoho; 1989 Dec; 16(12):3729-33. PubMed ID: 2596856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["AB-Triple V" therapy of relapsed or refractory acute myelogenous leukemia].
    Asou N; Suzushima H; Hamasaki N; Goto J; Hidaka M; Akagi K; Kurisaki H; Sawatari T; Kawano F; Takatsuki K
    Rinsho Ketsueki; 1989 Feb; 30(2):169-74. PubMed ID: 2746873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["B-triple V" therapy as a initial induction treatment of acute leukemias].
    Yokomatsu Y; Sagawa H; Yamane T; Hiyoshi M; Sasaki A; Kishida T; Kojima K; Yoshikawa T; Sannomiya Y; Kawarabayashi K
    Rinsho Ketsueki; 1987 Nov; 28(11):1935-40. PubMed ID: 3446866
    [No Abstract]   [Full Text] [Related]  

  • 4. [A study of B-triple V (behenoyl-ara C, etoposide, vincristine, vinblastine) in acute leukemia].
    Kohsaki M; Nagai K; Kanamaru A; Takaku F; Kobayashi Y; Mizoguchi H; Akaboshi M; Tsuchiya J; Miyawaki S; Sawamura M
    Rinsho Ketsueki; 1988 Apr; 29(4):527-33. PubMed ID: 3043041
    [No Abstract]   [Full Text] [Related]  

  • 5. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["A-Triple-V" treatment of relapsed or refractory acute leukemia].
    Makino S; Araki Y; Tamura K; Seita M
    Rinsho Ketsueki; 1988 Sep; 29(9):1394-8. PubMed ID: 3216510
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study.
    Wrzesien-Kus A; Robak T; Jamroziak K; Wierzbowska A; Dmoszynska A; Adamczyk-Cioch M; Kuliczkowski K; Mazur G; Holowiecki J; Konopka L; Maj S; Marianska B; Zawilska K;
    Neoplasma; 2002; 49(6):405-11. PubMed ID: 12584589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Low-dose oral etoposide and subcutaneous injection of low-dose cytosine arabinoside (Et-A non i.v.) with or without minimum anthracycline for refractory acute non-lymphoblastic leukemia].
    Tsukaguchi M; Furukawa Y; Kitani T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1603-7. PubMed ID: 9725056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term intensive consolidation chemotherapy in the treatment of acute nonlymphocytic leukemia].
    Nagata K; Abe Y; Hatanaka T; Ito T; Saito M; Ono Y; Kamiya O; Ohara K
    Gan To Kagaku Ryoho; 1994 Feb; 21(2):231-6. PubMed ID: 8311494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
    Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
    Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM
    Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Response-oriented salvage chemotherapy with mitoxantrone, etoposide and enocitabine for previously treated acute myeloid leukemia. Tohoku Leukemia Study Group].
    Chubachi A; Kuriya S; Narigasawa Y; Meguro K; Endo K; Takami H; Sato S; Sasaki H; Shiga T; Maruyama Y
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2101-6. PubMed ID: 8607622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["A-triple-V" in refractory or relapsed acute myelocytic leukemia].
    Miyawaki S; Nemoto K; Wakamatsu R; Baba N; Yashiro K; Uchida S; Nakura M; Karasawa M; Takada M; Tanaka H
    Rinsho Ketsueki; 1987 Jan; 28(1):34-9. PubMed ID: 3471982
    [No Abstract]   [Full Text] [Related]  

  • 16. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
    Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
    Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An intensive chemotherapy of adult T-cell leukemia/lymphoma].
    Taguchi H
    Rinsho Ketsueki; 1996 Aug; 37(8):654-60. PubMed ID: 8827873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Savani B
    Neoplasma; 1999; 46(1):61-5. PubMed ID: 10355536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide in combination with cytarabine, doxorubicin, and 6-thioguanine for treatment of acute nonlymphoblastic leukemia in a protocol adjusted for age.
    Bern MM; Wallach SR; Arkin CF; Lokich JJ; Huberman MS; Anderson NR; Corkery JC; Paul SD; Phillips DF; Sonneborn HA
    Cancer Treat Rep; 1987 Feb; 71(2):201-3. PubMed ID: 3802115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.